591 related articles for article (PubMed ID: 36228868)
1. Glutamatergic systems in neuropathic pain and emerging non-opioid therapies.
Temmermand R; Barrett JE; Fontana ACK
Pharmacol Res; 2022 Nov; 185():106492. PubMed ID: 36228868
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice.
Morioka N; Zhang FF; Nakamura Y; Kitamura T; Hisaoka-Nakashima K; Nakata Y
Brain Behav Immun; 2015 Oct; 49():293-310. PubMed ID: 26116449
[TBL] [Abstract][Full Text] [Related]
3. Neuronal glutamate transporter EAAT4 is expressed in astrocytes.
Hu WH; Walters WM; Xia XM; Karmally SA; Bethea JR
Glia; 2003 Oct; 44(1):13-25. PubMed ID: 12951653
[TBL] [Abstract][Full Text] [Related]
4. The glutamatergic system as a target for neuropathic pain relief.
Osikowicz M; Mika J; Przewlocka B
Exp Physiol; 2013 Feb; 98(2):372-84. PubMed ID: 23002244
[TBL] [Abstract][Full Text] [Related]
5. Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.
Zaitsev AV; Smolensky IV; Jorratt P; Ovsepian SV
CNS Drugs; 2020 Nov; 34(11):1089-1103. PubMed ID: 32926322
[TBL] [Abstract][Full Text] [Related]
6. Suppressing SNAP-25 and reversing glial glutamate transporters relieves neuropathic pain in rats by ameliorating imbalanced neurotransmission.
Liu C; Guo QL; Huang CS; Zou WY; Song ZB
Chin Med J (Engl); 2013 Nov; 126(21):4100-4. PubMed ID: 24229681
[TBL] [Abstract][Full Text] [Related]
7. Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain.
Yogeeswari P; Semwal A; Mishra R; Sriram D
Expert Opin Ther Targets; 2009 Aug; 13(8):925-43. PubMed ID: 19538098
[TBL] [Abstract][Full Text] [Related]
8. High-affinity glutamate transporters in chronic pain: an emerging therapeutic target.
Gegelashvili G; Bjerrum OJ
J Neurochem; 2014 Dec; 131(6):712-30. PubMed ID: 25270665
[TBL] [Abstract][Full Text] [Related]
9. Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.
Roberts RC; Roche JK; McCullumsmith RE
Neuroscience; 2014 Sep; 277():522-40. PubMed ID: 25064059
[TBL] [Abstract][Full Text] [Related]
10. Glutamate Transporters and Mitochondria: Signaling, Co-compartmentalization, Functional Coupling, and Future Directions.
Robinson MB; Lee ML; DaSilva S
Neurochem Res; 2020 Mar; 45(3):526-540. PubMed ID: 32002773
[TBL] [Abstract][Full Text] [Related]
11. The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain.
Kristensen PJ; Gegelashvili G; Munro G; Heegaard AM; Bjerrum OJ
Eur J Pain; 2018 Feb; 22(2):282-294. PubMed ID: 28984398
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.
Martinez-Lozada Z; Guillem AM; Robinson MB
Adv Pharmacol; 2016; 76():103-45. PubMed ID: 27288076
[TBL] [Abstract][Full Text] [Related]
13. The Role of Regulatory Transporters in Neuropathic Pain.
Yousuf MS; Kerr BJ
Adv Pharmacol; 2016; 75():245-71. PubMed ID: 26920015
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
[TBL] [Abstract][Full Text] [Related]
15. Astrocytic glutamate transporters reduce the neuronal and physiological influence of metabotropic glutamate receptors in nucleus tractus solitarii.
Martinez D; Rogers RC; Hermann GE; Hasser EM; Kline DD
Am J Physiol Regul Integr Comp Physiol; 2020 Mar; 318(3):R545-R564. PubMed ID: 31967862
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular physiology of sodium-dependent glutamate transporters.
Rose CR; Ziemens D; Untiet V; Fahlke C
Brain Res Bull; 2018 Jan; 136():3-16. PubMed ID: 28040508
[TBL] [Abstract][Full Text] [Related]
17. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.
Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
Neuropharmacology; 2019 Dec; 161():107559. PubMed ID: 30851309
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone increases astrocytic glutamate uptake and protects astrocytes and neurons against glutamate toxicity.
Mendes-de-Aguiar CB; Alchini R; Decker H; Alvarez-Silva M; Tasca CI; Trentin AG
J Neurosci Res; 2008 Nov; 86(14):3117-25. PubMed ID: 18543341
[TBL] [Abstract][Full Text] [Related]
19. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.
Li Y; Sattler R; Yang EJ; Nunes A; Ayukawa Y; Akhtar S; Ji G; Zhang PW; Rothstein JD
Neuropharmacology; 2011 Jun; 60(7-8):1168-75. PubMed ID: 21034752
[TBL] [Abstract][Full Text] [Related]
20. Astrocytes: Glutamate transport and alternate splicing of transporters.
Lee A; Pow DV
Int J Biochem Cell Biol; 2010 Dec; 42(12):1901-6. PubMed ID: 20883814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
